Key result
Aortic pulse wave velocity measurements provide predictive utility for cardiovascular risk independent of standard brachial blood pressure, particularly in patients with ESRD.
Why the study?
Do arterial stiffness measurements (aortic PWV) provide independent predictive utility for cardiovascular risk in patients with CKD and ESRD?
Do arterial stiffness measurements (aortic PWV) provide independent predictive utility for cardiovascular risk in patients with CKD and ESRD?
Arterial stiffness, measured via aortic pulse wave velocity, is an important independent predictor of cardiovascular risk, particularly in patients with chronic kidney disease and ESRD.
Supports aortic PWV for ESRD risk stratification beyond brachial BP; leaves open whether targeting stiffness improves outcomes.
Arterial stiffness is recognized increasingly as an important component in the determination of cardiovascular risk, particularly in chronic kidney disease and ESRD populations. Although the technique has been around for nearly 100 yr, in the past 20 to 25 yr, pragmatic noninvasive approaches have allowed the incorporation of arterial stiffness measurements, usually in the form of aortic pulse wave velocity (PWV), into clinical assessment of patients. In populations with high cardiovascular risk, especially those with ESRD, aortic PWV measurements provide predictive utility independent of the standard brachial arterial BP measurements. This review briefly discusses the history of vascular dynamics, the determinants of PWV, and some of the available technologies in current use and concludes with a section on the relevance of arterial stiffness measurements in populations of particular interest to nephrologists.
No takes yet. Share an insight, caveat, or question.
DeLoach et al. (2008) conducted a review in Chronic kidney disease and ESRD. Arterial stiffness measurements (aortic pulse wave velocity) vs. Standard brachial arterial BP measurements was evaluated. Aortic pulse wave velocity measurements provide predictive utility for cardiovascular risk independent of standard brachial blood pressure, particularly in patients with ESRD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Clinical Journal of the American Society of Nephrology